Authors
Loading...
Structural analysis reveals how STI-571 binds the inactive catalytic domain in Abelson tyrosine kinase, suggesting a strategy for designing highly specific kinase inhibitors.
Schindler et al. (2000) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: